title: [Gilles de la Tourette syndrome].
abstract: OBJECTIVE
  To make a specific review of the definition and symptomatology of Gilles de la Tourette syndrome.
  
  
  CONCLUSIONS
  We made an basic syndrome evaluation and at the same time established a relationship with/between the most significant co-morbid features. We also refer briefly to current drug treatment and dosage and mention some of the most relevant side-effects of these drugs. The exact etiology of this disorder is still not fully understood but it is thought to be due to autosomal dominant inheritance, with marked penetration in males.
authors.affiliation: Servicio de Neurología, Hospital Nacional de Niños, San José, Costa Rica. nasell@sol.racsa.co.cr
authors.forename: F
authors.initials: F
authors.lastname: Sell-Salazar
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001676:Biofeedback, Psychology; D002648:Child; D002675:Child, Preschool; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D005879:Tourette Syndrome / Q000175:diagnosis / Q000235:genetics / Q000628:therapy
chemical_list: D000316:Adrenergic alpha-Agonists; D018492:Dopamine Antagonists